Regis Technologies
Siead Zegar has over 30 years of experience in the pharmaceutical industry, with a focus on process chemistry and development. They have held various roles at companies such as Regis Technologies, deCODE genetics, Surtec Inc., and Ele-Pelron Corporation. Their experience includes positions such as Director of Technical Operations and Process Chemistry, Associate Director of Process Chemistry, and Operations Manager. Siead Zegar has extensive expertise in process research and development, project management, and manufacturing and controls associated with small molecule pharmaceutical product development.
Siead Zegar's education history includes attending the University of Illinois, though no specific start or end year, degree name, or field of study is provided.
Regis Technologies
Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help advance drug candidates to market. Our services streamline and support your discovery, lead molecule development and drug commercialization – from process development and analytical development, to stability services and cGMP API manufacturing. Our facilities are routinely inspected by the FDA and other global regulatory authorities. With our extensive organic chemistry & separations expertise, Regis also manufactures an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicagoland area since 1956.